Psychosomatic; Disorder, MultipleNCT06164782
A Survey on Psychosomatic Health Status of Chinese Population
An observational study of Psychosomatic; Disorder, Multiple and Well-Being, Psychological, run by Yonggui Yuan.
Trial summary
A Survey on Psychosomatic Health Status of Chinese Population Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Psychosomatic; Disorder, Multiple, Well-Being, Psychological
- How many people
- 300,000 participants
- Where
- No sites listed yet
- Study dates
- 17 Dec 2023to 31 Jan 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: General population in China
Who may be able to join
- Age 18 years old and above;
- Able to complete the scale independently;
- Subjects read informed consent through online questionnaires and agreed to cooperate with relevant assessments.
Who cannot join
- Individuals with severe physical disease;
- Individuals with cognitive impairment;
- Individuals who cannot finish the online survay independently.
Trial locations and contacts
No sites are listed yet.
About this study
A Survey on Psychosomatic Health Status of Chinese Population
Read the detailed description
This is a nationwide cross-sectional study to investigate psychosomatic symptoms among genral population in China. This study will also focus on the relationship between psychosomatic symptoms and functions and wellbeing.
- Medical subject headings
- Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| General Pupulation of China | General Pupulation of China |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psychosomatic health status
symptoms severity measured by the symptoms checklist of this study
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Dec 2023
- Study start17 Dec 2023 (estimated)
- Primary completion31 Jan 2024 (estimated)
- Study completion31 Jan 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Psychosomatic; Disorder, MultipleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 300,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Yonggui Yuan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Yonggui Yuan, Zhongda Hospital
- Investigators
- Yonggui Yuan, Prof., Study chair, Zhongda Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06164782
- Sponsor's protocol ID
- CN_Psychosomatic_20231201
- Status last verified
- Dec 2023
- First submitted
- 1 Dec 2023
- Last updated
- 22 Dec 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Survey on Psychosomatic Health Status of Chinese Population
- ClinicalTrials.gov ID
- NCT06164782
- Acronym / sponsor ID
- CN_Psychosomatic_20231201
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 300,000 participants (estimated)
- Lead sponsor
- Yonggui YuanUniversity, hospital or other
- Study start
- 17 Dec 2023 (estimated)
- Primary completion
- 31 Jan 2024 (estimated)
- Study completion
- 31 Jan 2024 (estimated)
- First posted
- 11 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A Survey on Psychosomatic Health Status of Chinese Population
Detailed description
This is a nationwide cross-sectional study to investigate psychosomatic symptoms among genral population in China. This study will also focus on the relationship between psychosomatic symptoms and functions and wellbeing.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| General Pupulation of China | – | –General Pupulation of China |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- General population in China
Key inclusion criteria (3 listed)
- Age 18 years old and above;
- Able to complete the scale independently;
- Subjects read informed consent through online questionnaires and agreed to cooperate with relevant assessments.
Key exclusion criteria (3 listed)
- Individuals with severe physical disease;
- Individuals with cognitive impairment;
- Individuals who cannot finish the online survay independently.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Psychosomatic health status
Time frame: Baseline
symptoms severity measured by the symptoms checklist of this study
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2023.
Related trials for Psychosomatic; Disorder, Multiple
Not yet recruiting
Bridging Gaps in the Multidimensional Assessment and Management of Overlapping Symptoms in Multiple Sclerosis and Functional Motor Disorders: Prevalence and Rehabilitation Effectiveness
Multiple Sclerosis, Functional Neurological Disorders
Not yet recruitingObservational study
Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological Determinants
Functional Neurological Disorders, Multiple Sclerosis
Not yet recruiting
Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?
Multiple Sclerosis, RRMS
Not yet recruitingObservational study
The NRC Dataset. Developing a Minimum Dataset for Multidisciplinary Rehabilitation: a Modified E-Delphi Study
Pain, Traumatic Brain Injury
Recruiting
Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.
Obsessive-Compulsive Disorder, Body Dysmorphic Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yonggui Yuan, Prof. study chair
Zhongda Hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Psychosomatic; Disorder, Multiple and Well-Being, Psychological, run by Yonggui Yuan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Yonggui Yuan, Prof. (+86-13913939082, yygylh2000@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Psychosomatic health status (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2023.